These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30394904)

  • 1. Recent developments in understanding the relationship between 22q11.2 deletion syndrome and psychosis.
    O'Rourke L; Murphy KC
    Curr Opin Psychiatry; 2019 Mar; 32(2):67-72. PubMed ID: 30394904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.
    Tang SX; Moore TM; Calkins ME; Yi JJ; Savitt A; Kohler CG; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Gur RC; Gur RE
    Biol Psychiatry; 2017 Jul; 82(1):17-25. PubMed ID: 27832840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.
    Niarchou M; Calkins ME; Moore TM; Tang SX; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Schizophr Bull; 2018 Jun; 44(4):824-833. PubMed ID: 29040797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.
    Weisman O; Guri Y; Gur RE; McDonald-McGinn DM; Calkins ME; Tang SX; Emanuel B; Zackai EH; Eliez S; Schneider M; Schaer M; Kates WR; Antshel KM; Fremont W; Shashi V; Hooper SR; Armando M; Vicari S; Pontillo M; Kushan L; Jalbrzikowski M; Bearden CE; Cubells JF; Ousley OY; Walker EF; Simon TJ; Stoddard J; Niendam TA; van den Bree MBM; Gothelf D;
    Schizophr Bull; 2017 Sep; 43(5):1079-1089. PubMed ID: 28204757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.
    Schneider M; Debbané M; Bassett AS; Chow EW; Fung WL; van den Bree M; Owen M; Murphy KC; Niarchou M; Kates WR; Antshel KM; Fremont W; McDonald-McGinn DM; Gur RE; Zackai EH; Vorstman J; Duijff SN; Klaassen PW; Swillen A; Gothelf D; Green T; Weizman A; Van Amelsvoort T; Evers L; Boot E; Shashi V; Hooper SR; Bearden CE; Jalbrzikowski M; Armando M; Vicari S; Murphy DG; Ousley O; Campbell LE; Simon TJ; Eliez S;
    Am J Psychiatry; 2014 Jun; 171(6):627-39. PubMed ID: 24577245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis of 22q11.2 deletion syndrome in the context of newly developed psychosis].
    Kaltenboeck A; Friedrich F; Hinterbuchinger B; Litvan Z; Mossaheb N
    Neuropsychiatr; 2016 Dec; 30(4):223-226. PubMed ID: 27822729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social cognition and real-life functioning in patient samples with 22q11.2 deletion syndrome with or without psychosis, compared to a large sample of patients with schizophrenia only and healthy controls.
    Frascarelli M; Accinni T; Buzzanca A; Carlone L; Ghezzi F; Moschillo A; Kotzalidis GD; Bucci P; Giordano GM; Fanella M; Di Bonaventura C; Putotto C; Marino B; Pasquini M; Biondi M; Di Fabio F
    J Neuropsychol; 2023 Sep; 17(3):564-583. PubMed ID: 37159847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome.
    Thompson CA; Karelis J; Middleton FA; Gentile K; Coman IL; Radoeva PD; Mehta R; Fremont WP; Antshel KM; Faraone SV; Kates WR
    Am J Med Genet B Neuropsychiatr Genet; 2017 Apr; 174(3):295-314. PubMed ID: 28139055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study.
    Gothelf D; Schneider M; Green T; Debbané M; Frisch A; Glaser B; Zilkha H; Schaer M; Weizman A; Eliez S
    J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1192-1203.e3. PubMed ID: 24157393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia.
    Van L; Boot E; Bassett AS
    Curr Opin Psychiatry; 2017 May; 30(3):191-196. PubMed ID: 28230630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trajectories of psychiatric diagnoses and medication usage in youth with 22q11.2 deletion syndrome: a 9-year longitudinal study.
    Kates WR; Mariano MA; Antshel KM; Chandra S; Gamble H; Giordano M; MacMaster E; Mattar M; St Fleur D; Faraone SV; Fremont WP
    Psychol Med; 2019 Aug; 49(11):1914-1922. PubMed ID: 30226117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and side effects of psychopharmacotherapy in individuals with 22q11.2 deletion syndrome with comorbid psychiatric disorders: a systematic review.
    Mosheva M; Korotkin L; Gur RE; Weizman A; Gothelf D
    Eur Child Adolesc Psychiatry; 2020 Aug; 29(8):1035-1048. PubMed ID: 30949827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of psychiatric comorbidity and cognitive deficit on function in 22q11.2 deletion syndrome.
    Yi JJ; Calkins ME; Tang SX; Kohler CG; McDonald-McGinn DM; Zackai EH; Savitt AP; Bilker WB; Whinna DA; Souders MC; Emanuel BS; Gur RC; Gur RE
    J Clin Psychiatry; 2015 Oct; 76(10):e1262-70. PubMed ID: 26528648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathways to understanding psychosis through rare - 22q11.2DS - and common variants.
    Gur RE; Roalf DR; Alexander-Bloch A; McDonald-McGinn DM; Gur RC
    Curr Opin Genet Dev; 2021 Jun; 68():35-40. PubMed ID: 33571729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.
    Tang SX; Yi JJ; Calkins ME; Whinna DA; Kohler CG; Souders MC; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Psychol Med; 2014 Apr; 44(6):1267-77. PubMed ID: 24016317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of functional brain architecture in 22q11.2 deletion syndrome - Insights into susceptibility for psychosis.
    Larsen KM; Dzafic I; Siebner HR; Garrido MI
    Neuroimage; 2019 Apr; 190():154-171. PubMed ID: 30195053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental radiologic findings in the 22q11.2 deletion syndrome.
    Schmitt JE; Yi JJ; Roalf DR; Loevner LA; Ruparel K; Whinna D; Souders MC; McDonald-McGinn DM; Yodh E; Vandekar S; Zackai EH; Gur RC; Emanuel BS; Gur RE
    AJNR Am J Neuroradiol; 2014; 35(11):2186-91. PubMed ID: 24948496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
    Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
    Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying patterns of anxiety and depression in children with chromosome 22q11.2 deletion syndrome: comorbidity predicts behavioral difficulties and impaired functional communications.
    Stephenson DD; Beaton EA; Weems CF; Angkustsiri K; Simon TJ
    Behav Brain Res; 2015 Jan; 276():190-8. PubMed ID: 24906195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.